Biotechnology Stocks
Some of the top Biotechnology stocks now:
Vertex Pharmaceuticals Inc (VRTX +2.25%), Moderna, Inc. Common Stock (MRNA +5.07%), Regeneron Pharmaceuticals Inc (REGN +2.90%), argenx SE American Depositary Shares (ARGX +3.51%).
The table below shows a total of 593 Biotechnology stocks, each contributes to the landscape of the Biotechnology industry. You can easily customize the table by ranking stocks based on price, volume or market cap according to your specific investing preferences.
| Symbol | Name | Price | % (1D) | Volume | Market Cap | Price Chart (1D) â–¾ | |
|---|---|---|---|---|---|---|---|
|
Vertex Pharmaceuticals Inc
|
509.72
|
+2.25% |
753.58K |
129.19B |
|
||
|
Moderna, Inc. Common Stock
|
237.78
|
+5.07% |
11.94M |
94.93B |
|
||
|
Regeneron Pharmaceuticals Inc
|
800.91
|
+2.90% |
471.30K |
82.46B |
|
||
|
argenx SE American Depositary Shares
|
847.02
|
+3.51% |
224.24K |
53.27B |
|
||
|
BeOne Medicines Ltd. American Depositary Shares
|
371.37
|
+5.66% |
356.54K |
42.01B |
|
||
|
Revolution Medicines, Inc. Common Stock
|
190.92
|
-1.34% |
724.22K |
40.92B |
|
||
|
Alnylam Pharmaceuticals, Inc.
|
233.00
|
+3.80% |
714.59K |
31.18B |
|
||
|
Royalty Pharma plc Class A Ordinary Shares
|
59.91
|
+1.55% |
1.36M |
26.67B |
|
||
|
Roivant Sciences Ltd. Common Shares
|
34.02
|
+1.20% |
1.49M |
24.58B |
|
||
|
Genmab A/S ADS
|
37.98
|
+2.94% |
2.52M |
23.35B |
|
||
|
Incyte Genomics Inc
|
113.88
|
+2.07% |
690.22K |
23.08B |
|
||
|
BioNTech SE American Depositary Share
|
90.22
|
+1.75% |
466.49K |
22.66B |
|
||
|
Insmed, Inc.
|
98.32
|
+0.54% |
1.41M |
21.47B |
|
||
|
Exelixis Inc
|
63.02
|
+3.33% |
1.43M |
15.62B |
|
||
|
Ascendis Pharma A/S Ordinary Share
|
227.22
|
+0.10% |
134.17K |
14.95B |
|
||
|
Jazz Pharmaceuticals, Inc.
|
214.46
|
+2.29% |
460.64K |
13.92B |
|
||
|
Halozyme Therapeutics, Inc.
|
121.51
|
+4.01% |
1.17M |
13.79B |
|
||
|
BridgeBio Pharma, Inc. Common Stock
|
67.09
|
+3.31% |
1.02M |
13.12B |
|
||
|
Corcept Therapeutics Inc.
|
114.26
|
-1.69% |
310.17K |
12.35B |
|
||
|
Summit Therapeutics Inc. Common Stock
|
15.36
|
+1.52% |
2.83M |
12.25B |
|
||
|
Bio-Techne Corp.
|
72.53
|
+0.04% |
1.61M |
11.37B |
|
||
|
BioMarin Pharmaceuticals Inc
|
56.67
|
+2.78% |
1.17M |
10.97B |
|
||
|
ImmunityBio, Inc. Common Stock
|
10.06
|
+1.56% |
13.05M |
10.67B |
|
||
|
Madrigal Pharmaceuticals, Inc. Common Stock
|
456.94
|
-0.67% |
99,171 |
10.56B |
|
||
|
Vaxcyte, Inc. Common Stock
|
65.65
|
-2.81% |
920.20K |
10.33B |
|
||
|
Krystal Biotech, Inc. Common Stock
|
331.66
|
+0.29% |
115.65K |
9.82B |
|
||
|
Twist Bioscience Corporation Common Stock
|
143.55
|
-3.11% |
2.47M |
9.52B |
|
||
|
Kymera Therapeutics, Inc. Common Stock
|
107.61
|
+0.73% |
196.43K |
8.95B |
|
||
|
Cytokinetics Inc.
|
64.08
|
+1.03% |
677.93K |
8.91B |
|
||
|
Protagonist Therapeutics, Inc
|
137.31
|
+0.76% |
265.17K |
8.89B |
|
||
|
Caris Life Sciences, Inc. Common Stock
|
31.17
|
+3.02% |
1.61M |
8.81B |
|
||
|
Axsome Therapeutics, Inc
|
164.63
|
+1.49% |
393.52K |
8.62B |
|
||
|
TG Therapeutics, Inc.
|
55.90
|
+2.80% |
948.71K |
8.56B |
|
||
|
ARROWHEAD PHARMACEUTICALS, INC.
|
58.40
|
+0.05% |
1.04M |
8.25B |
|
||
|
Abivax SA American Depositary Shares
|
92.29
|
+4.90% |
753.25K |
8.05B |
|
||
|
Spyre Therapeutics, Inc. Common Stock
|
78.70
|
+0.09% |
551.39K |
7.35B |
|
||
|
Ionis Pharmaceuticals, Inc. Common Stock
|
43.95
|
+2.93% |
924.62K |
7.30B |
|
||
|
Praxis Precision Medicines, Inc. Common Stock
|
246.72
|
+3.22% |
294.34K |
6.89B |
|
||
|
Iovance Biotherapeutics, Inc. Common Stock
|
14.31
|
+0.74% |
5.32M |
6.48B |
|
||
|
Belite Bio, Inc American Depositary Shares
|
154.38
|
+1.09% |
78,873 |
6.22B |
|
||
|
Rhythm Pharmaceuticals, Inc. Common Stock
|
88.40
|
+1.95% |
151.47K |
6.09B |
|
||
|
Ligand Pharmaceuticals Inc.
|
301.99
|
+2.37% |
106.18K |
6.02B |
|
||
|
Immunovant, Inc. Common Stock
|
27.70
|
-0.70% |
755.62K |
5.72B |
|
||
|
CG Oncology, Inc. Common stock
|
62.15
|
+0.50% |
233.31K |
5.51B |
|
||
|
Mirum Pharmaceuticals, Inc. Common Stock
|
82.29
|
+2.91% |
238.60K |
5.34B |
|
||
|
Kodiak Sciences Inc Common Stock
|
84.90
|
+4.70% |
694.62K |
5.34B |
|
||
|
Erasca, Inc. Common Stock
|
14.85
|
+1.02% |
2.36M |
5.19B |
|
||
|
PTC Therapeutics, Inc.
|
61.09
|
+2.37% |
365.06K |
5.10B |
|
||
|
Cogent Biosciences, Inc. Common Stock
|
29.23
|
+3.84% |
987.81K |
5.07B |
|
||
|
Travere Therapeutics, Inc. Common Stock
|
53.11
|
-0.30% |
985.73K |
5.01B |
|
||
|
CRISPR Therapeutics AG
|
51.43
|
+2.41% |
640.06K |
4.97B |
|
||
|
Scholar Rock Holding Corporation Common Stock
|
40.68
|
+2.73% |
846.02K |
4.95B |
|
||
|
Oruka Therapeutics, Inc. Common Stock
|
73.83
|
-3.72% |
441.05K |
4.89B |
|
||
|
Veradermics, Incorporated
|
114.42
|
+0.84% |
364.69K |
4.78B |
|
||
|
Definium Therapeutics, Inc. Common Shares
|
34.48
|
+0.70% |
741.02K |
4.63B |
|
||
|
Dianthus Therapeutics, Inc. Common Stock
|
73.97
|
-1.06% |
388.30K |
4.14B |
|
||
|
Edgewise Therapeutics, Inc. Common Stock
|
38.00
|
+2.65% |
719.29K |
4.13B |
|
||
|
AbCellera Biologics Inc. Common Shares
|
12.52
|
+1.21% |
3.95M |
4.06B |
|
||
|
Legend Biotech Corporation American Depositary Shares
|
19.71
|
+3.52% |
868.80K |
3.83B |
|
||
|
Relay Therapeutics, Inc. Common Stock
|
17.45
|
+2.29% |
883.27K |
3.82B |
|
||
|
Tango Therapeutics, Inc.
|
22.29
|
+0.45% |
1.50M |
3.76B |
|
||
|
Arcutis Biotherapeutics, Inc. Common Stock
|
28.46
|
+7.78% |
1.90M |
3.58B |
|
||
|
Telix Pharmaceuticals Limited American Depositary Shares
|
10.53
|
-1.17% |
94,535 |
3.58B |
|
||
|
Tarsus Pharmaceuticals, Inc. Common Stock
|
73.10
|
+1.12% |
391.19K |
3.42B |
|
||
|
Viking Therapeutics, Inc
|
26.85
|
+5.42% |
3.07M |
3.41B |
|
||
|
Acadia Pharmaceuticals Inc.
|
19.66
|
+2.13% |
569.62K |
3.39B |
|
||
|
Xenon Pharmaceuticals Inc
|
34.58
|
+2.01% |
645.46K |
3.35B |
|
||
|
IDEAYA Biosciences, Inc. Common Stock
|
33.83
|
-0.09% |
304.05K |
3.26B |
|
||
|
Parabilis Medicines, Inc. Common Stock
|
25.87
|
-0.08% |
288.57K |
3.20B |
|
||
|
Celcuity Inc. Common Stock
|
60.51
|
+1.01% |
852.36K |
2.96B |
|
||
|
Denali Therapeutics Inc. Common Stock
|
18.39
|
+2.91% |
669.10K |
2.94B |
|
||
|
Enliven Therapeutics, Inc. Common Stock
|
39.82
|
+1.37% |
503.24K |
2.92B |
|
||
|
Arcus Biosciences, Inc.
|
22.83
|
+1.33% |
590.25K |
2.91B |
|
||
|
Dyne Therapeutics, Inc. Common Stock
|
15.19
|
+1.00% |
982.19K |
2.84B |
|
||
|
Nurix Therapeutics, Inc. Common stock
|
24.71
|
+4.39% |
1.30M |
2.70B |
|
||
|
Zai Lab Limited American Depositary Shares
|
23.59
|
+4.82% |
324.25K |
2.65B |
|
||
|
Precigen, Inc. Common Stock
|
7.335
|
-0.27% |
2.02M |
2.63B |
|
||
|
NewAmsterdam Pharma Company N.V. Ordinary Shares
|
20.95
|
+4.70% |
354.95K |
2.50B |
|
||
|
Beam Therapeutics Inc. Common Stock
|
24.22
|
+2.41% |
899.73K |
2.50B |
|
||
|
ADMA Biologics, Inc.
|
10.74
|
+3.87% |
1.14M |
2.41B |
|
||
|
MBX Biosciences, Inc. Common Stock
|
49.57
|
+1.54% |
106.76K |
2.39B |
|
||
|
SELLAS Life Sciences Group, Inc. Common Stock
|
11.39
|
-4.13% |
3.03M |
2.30B |
|
||
|
Recursion Pharmaceuticals, Inc. Class A Common Stock
|
4.22
|
+12.83% |
44.81M |
2.26B |
|
||
|
Celldex Therapeutics, Inc
|
28.75
|
+3.29% |
340.57K |
2.26B |
|
||
|
Harmony Biosciences Holdings, Inc. Common Stock
|
38.60
|
+2.91% |
264.32K |
2.25B |
|
||
|
Aurinia Pharmaceuticals Inc
|
16.74
|
+0.78% |
499.45K |
2.23B |
|
||
|
Viridian Therapeutics, Inc. Common Stock
|
19.56
|
+6.42% |
1.06M |
2.22B |
|
||
|
Disc Medicine, Inc. Common Stock
|
57.63
|
+3.39% |
129.34K |
2.21B |
|
||
|
Fortrea Holdings Inc. Common Stock
|
22.28
|
+4.39% |
1.04M |
2.12B |
|
||
|
Vericel Corporation
|
41.34
|
+2.71% |
202.69K |
2.12B |
|
||
|
Novavax Inc
|
12.79
|
+1.23% |
4.20M |
2.11B |
|
||
|
Pharvaris N.V. Ordinary Shares
|
29.46
|
-1.87% |
331.27K |
2.07B |
|
||
|
Immunome, Inc.
|
17.34
|
+0.81% |
404.17K |
2.05B |
|
||
|
Vera Therapeutics, Inc. Class A Common Stock
|
28.36
|
+6.08% |
569.98K |
2.04B |
|
||
|
Lakefront Biotherapeutics American Depositary Shares
|
30.00
|
+2.04% |
146.20K |
1.96B |
|
||
|
Mineralys Therapeutics, Inc. Common Stock
|
21.66
|
+4.34% |
449.48K |
1.91B |
|
||
|
Agios Pharmaceuticals, Inc.
|
32.04
|
+3.45% |
649.60K |
1.91B |
|
||
|
ADARx Pharmaceuticals, Inc. Common Stock
|
17.83
|
+0.73% |
285.48K |
1.90B |
|
||
|
Sarepta Therapeutics,, Inc. Common Stock
|
17.71
|
+5.23% |
1.86M |
1.87B |
|
||
|
Zymeworks Inc.
|
25.87
|
+4.44% |
279.49K |
1.86B |
|
||
|
UroGen Pharma Ltd. Ordinary Shares
|
37.10
|
+1.42% |
158.60K |
1.81B |
|
||
|
Palvella Therapeutics, Inc. Common Stock
|
125.52
|
+2.40% |
75,440 |
1.81B |
|
||
|
Mesoblast Limited American Depositary Shares
|
13.87
|
+0.58% |
89,896 |
1.80B |
|
||
|
Xencor, Inc.
|
24.07
|
+2.91% |
186.18K |
1.79B |
|
||
|
Vir Biotechnology, Inc. Common Stock
|
10.49
|
+0.77% |
746.17K |
1.78B |
|
||
|
Septerna, Inc. Common Stock
|
37.38
|
+2.92% |
109.79K |
1.74B |
|
||
|
Braveheart Bio, Inc. Common Stock
|
19.34
|
+0.05% |
462.85K |
1.74B |
|
||
|
Biohaven Ltd.
|
11.41
|
+4.44% |
634.58K |
1.72B |
|
||
|
Trevi Therapeutics, Inc. Common Stock
|
12.09
|
+0.25% |
683.43K |
1.72B |
|
||
|
Nuvation Bio Inc.
|
4.74
|
+1.28% |
1.97M |
1.66B |
|
||
|
Zenas BioPharma, Inc. Common Stock
|
25.50
|
+2.59% |
206.79K |
1.66B |
|
||
|
Intellia Therapeutics, Inc
|
11.71
|
+2.49% |
1.90M |
1.64B |
|
||
|
Generate Biomedicines, Inc. Common Stock
|
12.75
|
+1.84% |
600.03K |
1.64B |
|
||
|
Ocular Therapeutix, Inc.
|
7.29
|
+1.25% |
1.22M |
1.60B |
|
||
|
Structure Therapeutics Inc. American Depositary Shares
|
22.25
|
+1.69% |
613.29K |
1.59B |
|
||
|
Stoke Therapeutics, Inc. Common Stock
|
24.23
|
+4.19% |
250.63K |
1.56B |
|
||
|
Korsana Biosciences, Inc. Common Stock
|
34.32
|
+8.40% |
193.57K |
1.56B |
|
||
|
Innoviva, Inc. Common Stock
|
21.05
|
+0.36% |
225.90K |
1.52B |
|
||
|
Maze Therapeutics, Inc. Common Stock
|
27.35
|
+4.28% |
263.10K |
1.52B |
|
||
|
Immunocore Holdings plc American Depositary Shares
|
29.32
|
+3.46% |
98,323 |
1.51B |
|
||
|
Absci Corporation Common Stock
|
8.79
|
+0.57% |
2.25M |
1.51B |
|
||
|
uniQure N.V.
|
21.73
|
+3.62% |
701.99K |
1.51B |
|
||
|
Hemab Therapeutics Holdings, Inc. Common Stock
|
32.26
|
+7.73% |
160.61K |
1.51B |
|
||
|
Ultragenyx Pharmaceutical Inc.
|
15.09
|
+1.24% |
1.49M |
1.49B |
|
||
|
Kailera Therapeutics, Inc. Common Stock
|
11.46
|
+6.70% |
530.32K |
1.49B |
|
||
|
Rapport Therapeutics, Inc. Common Stock
|
29.61
|
+4.52% |
139.11K |
1.42B |
|
||
|
AnaptysBio, Inc. Common Stock
|
47.44
|
+1.64% |
87,425 |
1.42B |
|
||
|
Ascentage Pharma Group International American Depository Shares
|
14.55
|
-2.02% |
4,370 |
1.36B |
|
||
|
Omeros Corporation
|
18.72
|
+1.57% |
324.45K |
1.36B |
|
||
|
Inhibrx Biosciences, Inc. Common Stock
|
90.12
|
+5.70% |
91,485 |
1.33B |
|
||
|
Tyra Biosciences, Inc. Common Stock
|
19.13
|
+2.30% |
180.60K |
1.32B |
|
||
|
Oric Pharmaceuticals, Inc. Common Stock
|
12.45
|
+7.42% |
490.68K |
1.29B |
|
||
|
Nektar Therapeutics
|
37.68
|
+2.14% |
366.89K |
1.29B |
|
||
|
GH Research PLC Ordinary Shares
|
18.63
|
+0.38% |
159.49K |
1.28B |
|
||
|
Kardigan, Inc. Common Stock
|
13.45
|
-0.52% |
209.65K |
1.26B |
|
||
|
First Tracks Biotherapeutics, Inc. Ordinary Shares
|
34.53
|
+1.17% |
830.36K |
1.23B |
|
||
|
Taysha Gene Therapies, Inc. Common Stock
|
3.765
|
+7.26% |
2.24M |
1.23B |
|
||
|
Alpha Tau Medical Ltd. Ordinary Shares
|
13.16
|
-2.48% |
288.58K |
1.22B |
|
||
|
Syndax Pharmaceuticals, Inc.
|
13.48
|
-0.37% |
960.12K |
1.20B |
|
||
|
LB Pharmaceuticals Inc Common Stock
|
36.44
|
+7.18% |
503.88K |
1.18B |
|
||
|
Bicara Therapeutics Inc. Common Stock
|
17.50
|
+0.89% |
249.08K |
1.16B |
|
||
|
Vor Biopharma Inc. Common Stock
|
19.48
|
+3.92% |
371.78K |
1.15B |
|
||
|
Nanobiotix S.A. American Depositary Shares
|
22.37
|
+5.12% |
53,018 |
1.14B |
|
||
|
Damora Therapeutics, Inc. Ordinary Shares
|
18.33
|
-0.54% |
95,811 |
1.13B |
|
||
|
Replimune Group, Inc.
|
11.72
|
+2.90% |
772.66K |
1.10B |
|
||
|
Avalyn Pharma Inc. Common Stock
|
24.64
|
+3.99% |
54,069 |
1.09B |
|
||
|
Immatics N.V. Ordinary Shares
|
7.11
|
+1.57% |
621.90K |
1.08B |
|
||
|
Janux Therapeutics, Inc. Common Stock
|
17.40
|
+1.58% |
217.36K |
1.06B |
|
||
|
Maravai LifeSciences Holdings, Inc. Class A Common Stock
|
6.825
|
+4.20% |
799.19K |
1.02B |
|
||
|
Mannkind Corporation
|
3.135
|
+3.81% |
1.97M |
1.01B |
|
||
|
Savara Inc.
|
4.76
|
+0.00% |
812.71K |
977.99M |
|
||
|
SL Science Holding Limited Ordinary Shares
|
1.71
|
+10.32% |
99,804 |
958.90M |
|
||
|
Seaport Therapeutics, Inc. Common Stock
|
17.62
|
+5.64% |
83,934 |
943.21M |
|
||
|
MeiraGTx Holdings plc Ordinary Shares
|
9.77
|
+3.83% |
323.40K |
938.34M |
|
||
|
Latigo Biotherapeutics, Inc. Common Stock
|
14.00
|
-10.88% |
222.50K |
928.19M |
|
||
|
Aktis Oncology, Inc. Common stock
|
16.29
|
-1.21% |
279.94K |
906.04M |
|
||
|
Alto Neuroscience Inc.
|
22.84
|
+5.20% |
205.76K |
896.29M |
|
||
|
Rigel Pharmaceuticals Inc. (New)
|
47.31
|
+1.05% |
77,538 |
883.74M |
|
||
|
MoonLake Immunotherapeutics Class A Ordinary Shares
|
10.36
|
+2.17% |
421.37K |
881.71M |
|
||
|
Jade Biosciences, Inc. Common Stock
|
13.80
|
+2.72% |
376.24K |
877.96M |
|
||
|
Cullinan Therapeutics, Inc. Common Stock
|
13.59
|
-0.37% |
432.70K |
874.58M |
|
||
|
Kura Oncology, Inc.
|
9.76
|
+1.56% |
859.95K |
868.26M |
|
||
|
Ardelyx, Inc.
|
3.315
|
+3.92% |
2.36M |
855.89M |
|
||
|
Verastem, Inc.
|
9.41
|
+22.05% |
8.75M |
852.20M |
|
||
|
Arbutus Biopharma Corporation Common Stock
|
4.285
|
+2.27% |
966.90K |
848.88M |
|
||
|
Monte Rosa Therapeutics, Inc. Common Stock
|
9.925
|
+0.86% |
370.97K |
846.74M |
|
||
|
Odyssey Therapeutics, Inc. Common Stock
|
17.41
|
+4.88% |
53,547 |
836.70M |
|
||
|
Corvus Pharmaceuticals, Inc.
|
9.89
|
+5.44% |
430.20K |
831.96M |
|
||
|
Alumis Inc. Common Stock
|
6.405
|
+5.69% |
1.08M |
829.03M |
|
||
|
SpyGlass Pharma, Inc. Common Stock
|
24.50
|
+3.42% |
8,917 |
819.48M |
|
||
|
ArriVent BioPharma, Inc. Common Stock
|
16.57
|
+2.25% |
226.17K |
816.78M |
|
||
|
Geron Corp
|
1.225
|
+2.94% |
2.29M |
787.03M |
|
||
|
Helus Pharma Inc.
|
10.71
|
+3.18% |
693.34K |
782.58M |
|
||
|
Ginkgo Bioworks Holdings, Inc.
|
11.51
|
-0.17% |
1.24M |
775.09M |
|
||
|
Adlai Nortye Group Ltd. American Depositary Shares
|
11.89
|
+9.28% |
426.59K |
765.69M |
|
||
|
Obsidian Therapeutics, Inc. Common Stock
|
12.22
|
+1.92% |
298.26K |
754.86M |
|
||
|
Sana Biotechnology, Inc. Common Stock
|
2.45
|
+5.15% |
1.47M |
733.43M |
|
||
|
Inventiva S.A. American Depository Shares
|
3.075
|
+7.14% |
1.90M |
726.42M |
|
||
|
Lexicon Pharmaceuticals, Inc.
|
1.625
|
+1.56% |
620.74K |
723.05M |
|
||
|
Immix Biopharma, Inc. Common Stock
|
8.67
|
+1.88% |
739.71K |
718.77M |
|
||
|
Apnimed, Inc. Common Stock
|
17.23
|
-3.37% |
1.01M |
717.30M |
|
||
|
Achieve Life Sciences, Inc.
|
6.84
|
-2.29% |
541.39K |
705.22M |
|
||
|
4D Molecular Therapeutics, Inc. Common Stock
|
12.58
|
+3.11% |
307.34K |
694.97M |
|
||
|
Pharming Group N.V. ADS, each representing 10 ordinary shares
|
9.815
|
+1.82% |
2,693 |
694.69M |
|
||
|
Gyre Therapeutics, Inc. Common Stock
|
6.49
|
+0.31% |
55,773 |
688.16M |
|
||
|
Attovia Therapeutics, Inc. Common Stock
|
15.07
|
+0.74% |
324.90K |
687.96M |
|
||
|
MiMedx Group, Inc
|
4.70
|
+0.00% |
738.20K |
685.89M |
|
||
|
Candel Therapeutics, Inc. Common Stock
|
8.92
|
-1.65% |
505.30K |
682.55M |
|
||
|
OmniAb, Inc. Common Stock
|
4.65
|
+2.20% |
293.36K |
676.07M |
|
||
|
Annexon, Inc. Common Stock
|
3.55
|
-3.27% |
1.28M |
673.01M |
|
||
|
Aura Biosciences, Inc. Common Stock
|
6.31
|
+2.27% |
300.18K |
654.38M |
|
||
|
Avalo Therapeutics, Inc. Common Stock
|
12.15
|
+2.66% |
408.89K |
651.87M |
|
||
|
Prime Medicine, Inc. Common Stock
|
3.495
|
+11.66% |
4.33M |
633.91M |
|
||
|
Design Therapeutics, Inc. Common Stock
|
10.09
|
+3.70% |
166.38K |
631.45M |
|
||
|
Nuvectis Pharma, Inc. Common Stock
|
19.01
|
+5.61% |
63,965 |
620.56M |
|
||
|
Climb Bio, Inc. Common Stock
|
10.78
|
+4.76% |
248.39K |
619.16M |
|
||
|
Phathom Pharmaceuticals, Inc. Common Stock
|
7.625
|
+3.04% |
529.25K |
616.87M |
|
||
|
Wave Life Sciences Ltd. Ordinary Shares
|
3.12
|
+0.97% |
1.41M |
614.79M |
|
||
|
Zevra Therapeutics, Inc. Common Stock
|
10.27
|
+0.39% |
191.87K |
609.87M |
|
||
|
Solid Biosciences Inc. Common Stock
|
5.65
|
+3.39% |
905.55K |
605.82M |
|